Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05257213 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Heparin Solution Versus Anti-adhesion Barrier Gel for Intrauterine Adhesions Prevention After Operative Hysteroscopy

StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated May 21, 2025 (before its estimated February 14, 2026 completion). Its status may not reflect the trial's current state.

Record History

See every version on ClinicalTrials.gov ↗

  1. Site details revised at 1 of 2 sitesv5
  2. Primary completion date: Feb 14, 2024 to Feb 14, 2026
    • Study sites: 1 to 2
    • Study completion date: Feb 28, 2024 to Feb 28, 2026
    v4
  3. Primary completion date: Feb 14, 2023 to Feb 14, 2024v3
  4. Primary endpoints revised (3)
    • Secondary endpoint revised
    • Study description expanded, about 1 word
    v2
  5. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The aim of this study is to compare the efficacy of intrauterine application of heparin solution to the use of hyaluronic acid barrier gel for the prevention of intrauterine adhesion formation after operative hysteroscopy.
Trial Details
NCT Number NCT05257213
Lead Sponsor Nadezhda Women's Health Hospital
Conditions
(from sponsor)		 Intrauterine Adhesion
Related terms Gynatresia
Enrollment 100 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov